Tectonic Therapeutic Inc (TECX) Stock Price, Quote & News

Company Profile

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treat...

Industry: Biotechnology

Sector: Healthcare

Phone: 339 666 3320

Website: tectonictx.com

Address:

490 Arsenal Way, Suite 210, Watertown, United States

hashhampton Jun. 20 at 1:55 PM

$TECX Back in after taking profits. I'm not sure if she'll go lower or not, but I'm anticipating that next week we'll go up to $23.00

0 · Reply

mb0157 Jun. 14 at 10:42 PM

$TECX took a position Friday. Will be adding more. This one was under my radar until I noticed institutions have been loading and Azn moving their drug candidate will give this validity. Solid risk reward play in my opinion.

0 · Reply

hashhampton Jun. 5 at 12:35 AM

$TECX Holding.

0 · Reply

hashhampton Jun. 3 at 8:07 PM

$TECX $30 coming!

0 · Reply

WallStArb Jun. 3 at 11:34 AM

$IKNA $1.42 - validation based on the PIPE buses puts PMVP price in the $2 area about $120M - it’s my largest position currently and just a waiting game like $TECX was when it was $AVRO

0 · Reply

WallStreetBuyDip Jun. 1 at 11:47 PM

$TECX Massive volume difference with 110,300 shares on May 30 compared to the average of 165,773. Price has been relatively stable around $21. Smart money waits for a lower H% to buy in.

0 · Reply

hashhampton Jun. 1 at 8:50 PM

$TECX Still bullish!

0 · Reply

hashhampton May. 30 at 10:04 PM

$TECX I was wrong. I admit it. I'm sorry, I apologize, my timing was off. $TECX is going to $27-$29, in the next week or two.

0 · Reply

hashhampton May. 23 at 10:37 PM

$TECX $27 next week! Maybe more. Stay tuned.

0 · Reply

hashhampton May. 22 at 11:34 PM

$TECX

0 · Reply

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025

May 8, 2025, 4:01 PM EDT - 6 weeks ago

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

Apr 23, 2025, 5:51 AM EDT - 2 months ago

Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF

Mar 20, 2025, 4:01 PM EDT - 3 months ago

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Feb 5, 2025, 11:36 AM EST - 4 months ago

Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data

Feb 3, 2025, 6:30 AM EST - 5 months ago

Tectonic Announces $185 Million Private Placement

Jan 30, 2025, 6:30 AM EST - 5 months ago

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

Jan 5, 2025, 7:30 AM EST - 6 months ago

Tectonic Therapeutic: Protein Engineering Platform For GPCRs

Dec 3, 2024, 4:01 PM EST - 7 months ago

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

Nov 26, 2024, 4:01 PM EST - 7 months ago

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

Nov 11, 2024, 5:00 AM EST - 8 months ago

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

Oct 22, 2024, 4:01 PM EDT - 8 months ago

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

Oct 20, 2024, 6:02 AM EDT - 8 months ago

Tectonic Therapeutic: Interesting CV Disease Drug Developer

Sep 19, 2024, 4:01 PM EDT - 9 months ago

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

Aug 20, 2024, 4:01 PM EDT - 10 months ago

Tectonic Therapeutic to Participate in September Investor Conferences

Aug 14, 2024, 4:01 PM EDT - 11 months ago

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights

Jul 30, 2024, 4:01 PM EDT - 11 months ago

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45

hashhampton Jun. 20 at 1:55 PM

$TECX Back in after taking profits. I'm not sure if she'll go lower or not, but I'm anticipating that next week we'll go up to $23.00

0 · Reply

mb0157 Jun. 14 at 10:42 PM

0 · Reply

hashhampton Jun. 5 at 12:35 AM

$TECX Holding.

0 · Reply

hashhampton Jun. 3 at 8:07 PM

$TECX $30 coming!

0 · Reply

WallStArb Jun. 3 at 11:34 AM

$IKNA $1.42 - validation based on the PIPE buses puts PMVP price in the $2 area about $120M - it’s my largest position currently and just a waiting game like $TECX was when it was $AVRO

0 · Reply

WallStreetBuyDip Jun. 1 at 11:47 PM

$TECX Massive volume difference with 110,300 shares on May 30 compared to the average of 165,773. Price has been relatively stable around $21. Smart money waits for a lower H% to buy in.

0 · Reply

hashhampton Jun. 1 at 8:50 PM

$TECX Still bullish!

0 · Reply

hashhampton May. 30 at 10:04 PM

$TECX I was wrong. I admit it. I'm sorry, I apologize, my timing was off. $TECX is going to $27-$29, in the next week or two.

0 · Reply

hashhampton May. 23 at 10:37 PM

$TECX $27 next week! Maybe more. Stay tuned.

0 · Reply

hashhampton May. 22 at 11:34 PM

$TECX

0 · Reply

stocksense2 May. 19 at 8:01 PM

$TECX

0 · Reply

ils85 May. 19 at 5:26 PM

$TECX about to run

0 · Reply

briefingcom May. 19 at 12:02 PM

Gapping up: $NVAX +14.3% $TXNM +9.6% $TECX +9.5% $KOLD +6% $FIP +4.3%

0 · Reply

knowthyself May. 17 at 8:48 PM

$TECX thoughts on data?

1 · Reply

AlertsAndNews May. 17 at 7:18 PM

$TECX Tectonic Therapeutic Reports Positive Phase 1b Results for TX45 in PH-HFpEF Patients Tectonic Therapeutic presented full Phase 1b data for TX45 at ESC Heart Failure 2025, showing the drug was well-tolerated and improved left ventricular function and pulmonary hemodynamics in patients with Group 2 PH-HFpEF. New echo analysis showed sustained hemodynamic effects lasting 29 days. Benefits were observed across a range of LVEF, including ≥50% and 41–49%

0 · Reply

Icarus81 May. 17 at 3:27 PM

$TECX Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025 https://finance.yahoo.com/news/tectonic-therapeutic-presents-complete-results-144000096.html

0 · Reply

Peachs May. 17 at 3:20 PM

$TECX new PR out?

0 · Reply

WallStArb May. 16 at 8:35 PM

$IKNA starting to accumulate for the merger and thinking this is similar to $TECX this time last year. $IKNA based on the $75M pipe is worth $2.25 a share into the merger where Orbimed DeepTrack BVF are paying. Seems low risk for a 3 month swing for easy 100% upside to fair value into the merger in a few weeks. Has upside as the new funds have skin in game and may push it like happened with $TECX 500% move $12 to $65

0 · Reply

hashhampton May. 16 at 1:16 PM

$TECX Rare gem. Bullish all the way! Good technicals, great pipeline, what's not to like? Added more yesterday and glad I did. $CLSK, $MARA, $QBTS, $VERV.

0 · Reply

hashhampton May. 15 at 4:57 PM

$TECX

0 · Reply

hashhampton May. 15 at 4:57 PM

$TECX What a great day, so far! $CLSK $QBTS $RGTI $LUNR

0 · Reply

hashhampton May. 15 at 3:31 PM

$TECX This is going to $60 plus by year's end. It's a no brainer people. Do your DD and you'll see what I'm seeing.

0 · Reply

Market Cap	369.91M
Revenue (ttm)	0.00
Net Income (ttm)	-57.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	149,141
Avg Vol	191,652
Day's Range	N/A - N/A
Shares Out	18.67M
Stochastic %K	11%
Beta	3.25
Analysts	Strong Sell
Price Target	$82.33